MTOR and renal cell carcinoma: Additionally, DEP domain containing 1 (DEPDC1) promotes glycolysis in RCC via the AKT/mTOR/HIF1α pathway, which in turn affects tumor metastasis and TKI resistance (Di et al., 2024).